TheEdgeResearch
Home / Stocks / CNMD

CONMED Corporation (CNMD)

NYSE Healthcare Medical - Devices
$46.56 ▲ +0.39%
Market Cap
$1.39B
Sector
Healthcare
Industry
Medical - Devices
Beta
0.90
52-Wk Range
31.44-54.8
CEO
Patrick J. Beyer
Country
US
Currency
USD

CONMED Corporation operates in the Medical - Devices industry of the Healthcare sector, headquartered in Largo, FL, US. The stock last traded at $46.56, up 0.39% on the session, giving a market capitalisation of $1.39B. On trailing twelve-month figures it carries a trailing P/E of 19.24, a net margin of 5.4%. Its beta of 0.90 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
19.24
Price / Sales
1.01
Price / Book
1.31
EV / EBITDA
10.20
Gross margin
57.2%
Operating margin
12.1%
Net margin
5.4%
Return on equity
—
Debt / equity
0.77
Current ratio
1.49
Dividend yield
0.0%
Payout ratio
8.4%
Company profile
Exchange
New York Stock Exchange
Employees
3,900
IPO date
1987-07-23
Headquarters
Largo, FL, US
About CONMED Corporation

CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.

More research on CNMD
CNMD technical analysis CNMD TheEdge Score Compare against peers
Open full interactive analysis & DCF →